CMS Opens National Coverage Determination (NCD) Analysis

For Remote Implantable Hemodynamic Monitoring for Heart Failure


On April 30, 2024, the Centers for Medicare and Medicaid Services (CMS) opened a National Coverage Determination Analysis and is soliciting public comments on this life-changing therapy. Abbott has requested an NCD consideration to create national coverage criteria to ensure long-term, predictable, and consistent coverage for all Medicare beneficiaries.

As part of opening the NCD analysis, CMS has opened a public comment period. This is an opportunity for all stakeholders (physicians, hospital administrators, patients, professional societies, industry, etc.) to provide feedback to CMS on the importance of the recent evidence on relevant patient characteristics for identifying coverage candidacy for remote implantable hemodynamic monitoring for heart failure.

Last day to enter comments is May 30, 2024. Once this public comment period closes, CMS will review the totality of clinical evidence on hemodynamic monitoring and the submitted comments to begin the development of a proposed NCD.

If you would like to submit a comment on the CMS website, please use the 'Submit NCD Comment' links provided. For more information regarding the NCD analysis, you can find it here.

If you have reimbursement questions, please contact us or you can call us at (855) 569-6430. Support is available from 8 a.m. to 5 p.m. Central Time, Monday through Friday.

Additionally, you can visit our website for reimbursement resources such as guides, general FAQs, and reimbursement webinars.

MAT-2302598 v1.0